UPDATE: Credit Suisse Reiterates On Esperion Therapeutics Inc On Multiple Positive Factors
October 02, 2014 at 08:51 AM EDT
In a report published Thursday, Credit Suisse analyst Jason Kantor reiterated an Outperform rating on Esperion Therapeutics Inc (NASDAQ: ...